国家卫生健康行业标准《儿科输血指南》造血干细胞移植患儿输血的编制说明与解读

黄蓉; 何庆南; 黑明燕; 竺晓凡; 卢俊; 徐晓军; 袁天明; 张蓉; 王旭; 刘晋萍; 王静; 邵智利; 赵明一; 郭永建; 吴心音; 陈佳睿; 陈琦蓉; 郭佳; 桂嵘; 杨明华

doi:10.7499/j.issn.1008-8830.2410094

PDF(497 KB)

HTML

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (2) : 139-143. DOI: 10.7499/j.issn.1008-8830.2410094

指南解读

国家卫生健康行业标准《儿科输血指南》造血干细胞移植患儿输血的编制说明与解读

黄蓉¹, 何庆南², 黑明燕³, 竺晓凡⁴, 卢俊⁵, 徐晓军⁶, 袁天明⁷, 张蓉⁸, 王旭⁹, 刘晋萍¹⁰, 王静¹¹, 邵智利¹², 赵明一², 郭永建^13,14, 吴心音¹⁵, 陈佳睿^16,17, 陈琦蓉^16,17, 郭佳^16,17, 桂嵘¹, 杨明华²

作者信息 +

Explanation and interpretation of the compilation of blood transfusion provisions for children undergoing hematopoietic stem cell transplantation in the national health standard "Guideline for pediatric transfusion"

HUANG Rong, HE Qing-Nan, HEI Ming-Yan, ZHU Xiao-Fan, LU Jun, XU Xiao-Jun, YUAN Tian-Ming, ZHANG Rong, WANG Xu, LIU Jin-Ping, WANG Jing, SHAO Zhi-Li, ZHAO Ming-Yi, GUO Yong-Jian, WU Xin-Yin, CHEN Jia-Rui, CHEN Qi-Rong, GUO Jia, GUI Rong, YANG Ming-Hua

Author information +

文章历史 +

摘要

为了指导儿童患者的临床输血实践，国家卫生健康委员会发布了卫生健康行业标准《儿科输血指南》（WS/T 795-2022）。造血干细胞移植患儿输血极具复杂性和挑战性，该指南对这些患儿的输血阈值、血液成分的选择给出了指导和建议。该文将介绍造血干细胞移植患儿输血条款内容的证据与解读，希望对《儿科输血指南》的理解和贯彻实施有所助益。

Abstract

To guide clinical blood transfusion practices for pediatric patients, the National Health Commission has issued the health standard "Guideline for pediatric transfusion" (WS/T 795-2022). Blood transfusion for children undergoing hematopoietic stem cell transplantation is highly complex and challenging. This guideline provides recommendations on transfusion thresholds and the selection of blood components for these children. This article presents the evidence and interpretation of the transfusion provisions for children undergoing hematopoietic stem cell transplantation, with the aim of enhancing the understanding and implementation of the "Guideline for pediatric transfusion".

导出引用

黄蓉, 何庆南, 黑明燕, 竺晓凡, 卢俊, 徐晓军, 袁天明, 张蓉, 王旭, 刘晋萍, 王静, 邵智利, 赵明一, 郭永建, 吴心音, 陈佳睿, 陈琦蓉, 郭佳, 桂嵘, 杨明华. 国家卫生健康行业标准《儿科输血指南》造血干细胞移植患儿输血的编制说明与解读[J]. 中国当代儿科杂志. 2025, 27(2): 139-143 https://doi.org/10.7499/j.issn.1008-8830.2410094

HUANG Rong, HE Qing-Nan, HEI Ming-Yan, ZHU Xiao-Fan, LU Jun, XU Xiao-Jun, YUAN Tian-Ming, ZHANG Rong, WANG Xu, LIU Jin-Ping, WANG Jing, SHAO Zhi-Li, ZHAO Ming-Yi, GUO Yong-Jian, WU Xin-Yin, CHEN Jia-Rui, CHEN Qi-Rong, GUO Jia, GUI Rong, YANG Ming-Hua. Explanation and interpretation of the compilation of blood transfusion provisions for children undergoing hematopoietic stem cell transplantation in the national health standard "Guideline for pediatric transfusion"[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(2): 139-143 https://doi.org/10.7499/j.issn.1008-8830.2410094

参考文献

1 中华人民共和国国家卫生健康委员会法规司. 关于发布《输血相容性检测标准》等3项推荐性卫生行业标准的通告: 国卫通〔2022〕1号[EB/OL]. (2022-02-23)[2022-09-01]. http://www.nhc.gov.cn/fzs/s7852d/202202/1484f47dcf824ee8bae3ad7b6809e603.shtml.
2 Avery RK, Adal KA, Longworth DL, et al. A survey of allogeneic bone marrow transplant programs in the United States regarding Cytomegalovirus prophylaxis and pre-emptive therapy[J]. Bone Marrow Transplant, 2000, 26(7): 763-767. PMID: 11042658. DOI: 10.1038/sj.bmt.1702608.
3 Lightdale JR, Randolph AG, Tran CM, et al. Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2012, 18(5): 813-817. PMID: 22080050. DOI: 10.1016/j.bbmt.2011.10.043.
4 Tay J, Allan DS, Chatelain E, et al. Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial[J]. J Clin Oncol, 2020, 38(13): 1463-1473. PMID: 32083994. DOI: 10.1200/JCO.19.01836.
5 McPherson ME, Anderson AR, Haight AE, et al. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor[J]. Transfusion, 2009, 49(9): 1977-1986. PMID: 19453984. DOI: 10.1111/j.1537-2995.2009.02213.x.
6 Crighton GL, Estcourt LJ, Wood EM, et al. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation[J]. Cochrane Database Syst Rev, 2015, 2015(9): CD010981. PMID: 26422767. PMCID: PMC4610062. DOI: 10.1002/14651858.CD010981.pub2.
7 Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study[J]. Lancet, 2012, 380(9850): 1309-1316. PMID: 22877506. DOI: 10.1016/S0140-6736(12)60689-8.
8 Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers[J]. N Engl J Med, 2013, 368(19): 1771-1780. PMID: 23656642. DOI: 10.1056/NEJMoa1212772.
9 Stanworth SJ, Estcourt LJ, Llewelyn CA, et al. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial[J]. Transfusion, 2014, 54(10): 2385-2393. PMID: 24724863. DOI: 10.1111/trf.12646.
10 Estcourt LJ, Stanworth SJ, Doree C, et al. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation[J]. Cochrane Database Syst Rev, 2015, 2015(11): CD010983. PMID: 26576687. PMCID: PMC4717525. DOI: 10.1002/14651858.CD010983.pub2.
11 Cohn CS, Delaney M, Johnson ST, et al. Technical Manual[M]. 20th ed. Bethesda: American Association of Blood Banks, 2020.
12 Meyer SC, O'Meara A, Buser AS, et al. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2013, 19(3): 440-444. PMID: 23089566. DOI: 10.1016/j.bbmt.2012.10.012.
13 Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation[J]. Bone Marrow Transplant, 2008, 42(12): 799-805. PMID: 18762767. DOI: 10.1038/bmt.2008.262.
14 Maradei SC, Maiolino A, de Azevedo AM, et al. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation[J]. Blood, 2009, 114(6): 1270-1275. PMID: 19401560. DOI: 10.1182/blood-2009-03-212282.
15 Mackinnon S, Papadopoulos EB, Carabasi MH, et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease[J]. Blood, 1995, 86(4): 1261-1268. PMID: 7632930.